全文获取类型
收费全文 | 293069篇 |
免费 | 19586篇 |
国内免费 | 1298篇 |
专业分类
耳鼻咽喉 | 3119篇 |
儿科学 | 7466篇 |
妇产科学 | 5870篇 |
基础医学 | 36590篇 |
口腔科学 | 5769篇 |
临床医学 | 29942篇 |
内科学 | 62655篇 |
皮肤病学 | 3984篇 |
神经病学 | 28301篇 |
特种医学 | 11844篇 |
外国民族医学 | 15篇 |
外科学 | 45925篇 |
综合类 | 3515篇 |
现状与发展 | 1篇 |
一般理论 | 272篇 |
预防医学 | 21521篇 |
眼科学 | 7252篇 |
药学 | 19563篇 |
1篇 | |
中国医学 | 448篇 |
肿瘤学 | 19900篇 |
出版年
2023年 | 1605篇 |
2022年 | 2613篇 |
2021年 | 6370篇 |
2020年 | 3699篇 |
2019年 | 5958篇 |
2018年 | 7163篇 |
2017年 | 5188篇 |
2016年 | 5731篇 |
2015年 | 6788篇 |
2014年 | 9973篇 |
2013年 | 13855篇 |
2012年 | 20689篇 |
2011年 | 21737篇 |
2010年 | 12218篇 |
2009年 | 11311篇 |
2008年 | 19499篇 |
2007年 | 20454篇 |
2006年 | 19879篇 |
2005年 | 19809篇 |
2004年 | 18636篇 |
2003年 | 16974篇 |
2002年 | 16314篇 |
2001年 | 2626篇 |
2000年 | 2025篇 |
1999年 | 2684篇 |
1998年 | 3460篇 |
1997年 | 2777篇 |
1996年 | 2377篇 |
1995年 | 2210篇 |
1994年 | 1962篇 |
1993年 | 1894篇 |
1992年 | 1485篇 |
1991年 | 1408篇 |
1990年 | 1177篇 |
1989年 | 1159篇 |
1988年 | 1057篇 |
1987年 | 971篇 |
1986年 | 979篇 |
1985年 | 1081篇 |
1984年 | 1313篇 |
1983年 | 1163篇 |
1982年 | 1530篇 |
1981年 | 1391篇 |
1980年 | 1302篇 |
1979年 | 761篇 |
1978年 | 818篇 |
1977年 | 757篇 |
1976年 | 668篇 |
1975年 | 591篇 |
1974年 | 546篇 |
排序方式: 共有10000条查询结果,搜索用时 83 毫秒
1.
Objective
The aim of the study was to estimate the effect of the state-based reinsurance programs through the section 1332 State Innovation Waivers on health insurance marketplace premiums and insurer participation.Data Source
2015 to 2022 Robert Wood Johnson Foundation Health Insurance Exchange Compare Datasets.Study Design
An event study difference-in-differences (DD) model separately for each year of implementation and a synthetic control method (SCM) are used to estimate year-by-year effects following program implementation.Data Collection/Extraction Methods
Not applicable.Principal Findings
Reinsurance programs were associated with a decline in premiums in the first year of implementation by 10%–13%, 5%–19%, and 11%–17% for bronze, silver, and gold plans (p < 0.05). There is a trend of sustained declines especially for states that implemented their programs in 2019 and 2020. The SCM analyses suggest some effect heterogeneity across states but also premium declines across most states. There is no evidence that reinsurance programs affected insurer participation.Conclusion
State-based reinsurance programs have the potential to improve the affordability of health insurance coverage. However, reinsurance programs do not appear to have had an effect on insurer participation, highlighting the need for policy makers to consider complementary strategies to encourage insurer participation. 相似文献2.
Kamolz Lars-Peter Kotzbeck Petra Schintler Michael Spendel Stephan 《European Surgery》2022,54(3):163-169
European Surgery - Large skin defects caused by trauma (e.g., burns) or due to other reasons (e.g., tumor-related skin resections) require sufficient skin replacement. The constant improvement of... 相似文献
3.
4.
5.
6.
Rajendrababu Sharmila Puthuran George Varghese Alia Laxmi Ananya Uduman Mohammed Sithiq Wijesinghe Hiruni Kaushalya 《International ophthalmology》2022,42(8):2609-2618
International Ophthalmology - To investigate the efficacy and safety of non-valved Aurolab aqueous drainage implant (AADI) surgery combined with phacoemulsification in eyes with refractory glaucoma... 相似文献
7.
8.
Victoria L. Parker Matthew C. Winter John A. Tidy Barry W. Hancock Julia E. Palmer Naveed Sarwar Baljeet Kaur Katie McDonald Xianne Aguiar Kamaljit Singh Nick Unsworth Imran Jabbar Allan A. Pacey Robert F. Harrison Michael J. Seckl 《International journal of cancer. Journal international du cancer》2023,152(5):986-997
Gestational trophoblastic neoplasia (GTN) patients are treated according to the eight-variable International Federation of Gynaecology and Obstetrics (FIGO) scoring system, that aims to predict first-line single-agent chemotherapy resistance. FIGO is imperfect with one-third of low-risk patients developing disease resistance to first-line single-agent chemotherapy. We aimed to generate simplified models that improve upon FIGO. Logistic regression (LR) and multilayer perceptron (MLP) modelling (n = 4191) generated six models (M1-6). M1, all eight FIGO variables (scored data); M2, all eight FIGO variables (scored and raw data); M3, nonimaging variables (scored data); M4, nonimaging variables (scored and raw data); M5, imaging variables (scored data); and M6, pretreatment hCG (raw data) + imaging variables (scored data). Performance was compared to FIGO using true and false positive rates, positive and negative predictive values, diagnostic odds ratio, receiver operating characteristic (ROC) curves, Bland-Altman calibration plots, decision curve analysis and contingency tables. M1-6 were calibrated and outperformed FIGO on true positive rate and positive predictive value. Using LR and MLP, M1, M2 and M4 generated small improvements to the ROC curve and decision curve analysis. M3, M5 and M6 matched FIGO or performed less well. Compared to FIGO, most (excluding LR M4 and MLP M5) had significant discordance in patient classification (McNemar's test P < .05); 55-112 undertreated, 46-206 overtreated. Statistical modelling yielded only small gains over FIGO performance, arising through recategorisation of treatment-resistant patients, with a significant proportion of under/overtreatment as the available data have been used a priori to allocate primary chemotherapy. Streamlining FIGO should now be the focus. 相似文献
9.
10.
Daniel Schar Pawin Padungtod Nguyen Tung Michael OLeary Wantanee Kalpravidh Filip Claes 《Influenza and other respiratory viruses》2019,13(6):618-621
Among the chief limitations in achieving early detection and control of animal‐origin influenza of pandemic potential in high‐risk livestock populations is the existing lag time between sample collection and diagnostic result. Advances in molecular diagnostics are permitting deployment of affordable, rapid, highly sensitive, and specific point‐of‐capture assays, providing opportunities for targeted surveillance driving containment strategies with potentially compelling returns on investment. Interrupting disease transmission at source holds promise of disrupting cycles of animal‐origin influenza incursion to endemicity and limiting impact on animal production, food security, and public health. Adoption of new point‐of‐capture diagnostics should be undertaken in the context of promoting robust veterinary services systems and parallel support for operationalizing pre‐authorized plans and communication strategies that will ensure that the full potential of these new platforms is realized. 相似文献